Ready for New Discoveries?

– Partner with a CRO you can count on

Disease Models

Cell Based Assays

Biosafety Class 2 Lab

Tissue Collection & Analysis

Preclinical CRO at Your Service

About Redoxis

Redoxis is a preclinical CRO for you who values a dedicated and personal partner. Our core expertise and focus are on preclinical drug development and efficacy evaluation in models of autoimmune disease.

With the roots in academic research we are continuously updating our portfolio of inflammatory and autoimmune disease models and are connected to the latest immunology research.

We take great pride in personal communication and commitment in our studies  – for the benefit of your preclinical project!

More about us

In Vitro and Ex vivo services

Services

In vitro and ex vivo assays are essential tools for exploring immune function, drug mechanisms, and cellular phenotypes in a controlled environment.

Our services

In Vivo

Services

Our services

Customer Reviews

\"BCI collaborates with Redoxis for many years and we really appreciate study discussions, planning, flexibility and study reports. Redoxis is a really competitive and expert CRO for in-vivo and in-vitro studies and with the sense of urgency. I really recommend to use their platform and expertise.\"
Dominique Surleraux, President and CEO
BCI Pharma
\"It was a real pleasure to communicate with Redoxis team and the performed studies fit very well to our expectancies. In other words, we are fully satisfied.\"
Sebastian Hannedouche
Euroscreen, Belgium
\"The report from Redoxis is an example of a good report\"
Lars Hornum, Senior Principal Scientist
LEO Pharma